Evidence map›Paper›PMID 31397805›Full record

ArticleTransplantation2019

Long-term Kinetics of Intragraft Gene Signatures in Renal Allograft Tolerance Induced by Transient Mixed Chimerism.

Masatoshi Matsunami, Ivy A Rosales, Benjamin A Adam, Tetsu Oura, Michael Mengel, Rex-Neal Smith, Hang Lee, A Benedict Cosimi, Robert B Colvin, Tatsuo Kawai

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Masatoshi MatsunamiDepartment of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Ivy A RosalesDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Benjamin A AdamDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Tetsu OuraDepartment of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Michael MengelDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Rex-Neal SmithDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Hang LeeDepartment of Biostatistics, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
A Benedict CosimiDepartment of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Robert B ColvinDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Tatsuo KawaiDepartment of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Harvard University · USMassachusetts General Hospital · USUniversity of Alberta · CA

Funding

XENOGENIC TOLERANCE IN MICEP01HL018646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1985 to 2019
$37.5M
Project 3: The Role of Erythropoietin in Kidney Transplant ToleranceP01AI123086 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 2016 to 2020
$10.6M
Tolerance to Composite Islet-Kidney Transplants in Non-Human PrimatesU19AI102405 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI COSIMI, A BENEDICT · 2012 to 2016
$7.7M
Inhibition of Bcl-2 for Induction of Mixed Chimerism and Renal Allograft Tolerance Without MyelosuppressionR56AI139679 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAWAI, TATSUO · 2018 to 2018
$678k
Inhibition of BCL-2 for induction of mixed chimerism without myelosuppressive conditioningR21AI126289 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAWAI, TATSUO · 2016 to 2017
$461k
NHLBI NIH HHS P01 HL018646NIAID NIH HHS P01 AI123086NIAID NIH HHS R21 AI126289NIAID NIH HHS R56 AI139679NIAID NIH HHS U19 AI102405
6 · The paper itself

Abstract

backgroundRenal allograft tolerance (TOL) has been successfully induced in nonhuman primates (NHPs) and humans through the induction of transient mixed chimerism. To elucidate the mechanisms of TOL, we compared local immunologic responses in renal allografts with those in T-cell-mediated rejection (TCMR) and chronic antibody-mediated rejection (CAMR) in NHPs.

methodsUsing the NanoString nCounter platform, we retrospectively studied 52 mRNAs in 256 kidney allograft samples taken from NHP kidney recipients of donor BMT. No immunosuppression was given after 1-month post-donor BMT. Recipients who achieved TOL (n = 13) survived for >1840 ± 1724 days with normal kidney function, while recipients with CAMR (n = 13) survived for 899 ± 550 days with compromised graft function, and recipients with TCMR (n = 15) achieved only short-term survival (132 ± 69 days).

resultsThe most prominent difference between the groups was FOXP3, which was significantly higher in TOL than in CAMR and TCMR, both early (<1 y, P < 0.01) and late (≥1 y, P < 0.05) after transplant. Other mRNAs related to regulatory T cells (Treg), such as IL10, TGFB, and GATA3, were also high in TOL. In contrast, transcripts of inflammatory cytokines were higher in TCMR, while activated endothelium-associated transcripts were higher in CAMR than in TOL. The receiver operating characteristic analyses revealed that intragraft FOXP3 and CAV1 can reliably distinguish TOL from CAMR.

conclusionsHigh FOXP3 and other Treg-related mRNAs together with suppressed inflammatory responses and endothelial activation in renal allografts suggest that intragraft enrichment of Treg is a critical mechanism of renal allograft TOL induced by transient mixed chimerism.

Indexed as

Kidney TransplantationTransplantation ToleranceAllograftsAnimalsBiomarkersBone Marrow TransplantationForkhead Transcription FactorsGATA3 Transcription FactorGenotypeGraft RejectionGraft SurvivalImmunosuppression TherapyInterleukin-10KidneyMacaca fascicularisMajor Histocompatibility ComplexBiomarkersForkhead Transcription FactorsGATA3 Transcription FactorInterleukin-10RNA, MessengerTransforming Growth Factor beta

Identifiers

PMID31397805
PMCPMC6814550
OpenAlexW2968238024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.